Skip to main navigation Skip to search Skip to main content

A 12-month, randomized, rater- and dose-blinded study to compare the efficacy and safety of fingolimod 0.25 mg and 0.5 mg administered orally once daily with galtiramer acetate 20 mg administered subcutaneously once daily in patients

Project: Research

Project Details

StatusFinished
Effective start/end date03/1/13 → 02/28/20

Funding

  • Novartis Pharmaceuticals Corporation: $74,407.77